Human Acellular News Today

Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte Fourth Quarter and Year-End 2022 Results Conference Call. Currently, all participants are in a listen-only mode.

GuruFocus Article or News written by GuruFocusNews and the topic is about:

27.06.2022 - Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companiesDURHAM, N.C., June 27, 2022 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage ...

Industry leader brings deep expertise in international drug development, strategic leadership, and corporate partnering for biopharmaceutical companies...

GuruFocus Article or News written by GuruFocusNews and the topic is about:

-- Five-year data demonstrate the potential of the Human Acellular VesselTM(HAV) to be a durable and safe option for vascular access for routine, long-term hemodialysis --

Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles - read this article along with other careers information, tips and advice on BioSpace

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment

31.12.2021 - DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) - Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of ... Seite 1